available for iOS, Android & web
March 21, 2014
Reverses earlier negative appraisal
November 11, 2013
But asks for more data to help determine value to NHS
May 12, 2011
Contamination of Johnson & Johnson's HIV drug Prezista (darunavir) with a fungicide has led to a recall of the product in some European countries and Canada.
March 10, 2011
Schizophrenia patients across the European Union are to get access to a new treatment option after European regulators issued a green light for Johnson & Johnson's Xeplion.
January 04, 2011
Janssen-Cilag International has been given the thumbs up by the European Commission for its antipsychotic drug Invega (paliperidone ER) – the first treatment for schizoaffective disorder in Europe.
August 31, 2010
Celgene’s Thalidomide and Janssen-Cilag’s Velcade have been recommended as options to treat patients with multiple myeloma on the National Health Service by its cost regulator.
August 27, 2010
Janssen-Cilag is to appeal the UK decision to restrict access to its multiple myeloma drug Velcade (bortezomib).
Recruitment agencies provide the unique bridge to [more]...
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions